Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 9272684)

Published in Neurosci Lett on July 25, 1997

Authors

I Reenilä1, P Tuomainen, S Soinila, P T Männistö

Author Affiliations

1: Institute of Biomedicine, Department of Pharmacology and Toxicology, University of Helsinki, Finland. ilkka.reenila@helsinki.fi

Articles by these authors

Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82

Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology (2011) 1.75

Comparative liver toxicity of various erythromycin derivatives in animals. J Antimicrob Chemother (1988) 1.41

On the role of prolyl oligopeptidase in health and disease. Neuropeptides (2006) 1.39

Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother (1982) 1.32

Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother (1983) 1.24

Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart (2006) 1.12

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors. J Med Chem (1989) 1.12

Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. Eur J Pharmacol (1988) 1.09

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Br J Pharmacol (1992) 1.02

Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse. Br J Anaesth (1976) 0.97

Pharmacokinetics of nalidixinic acid and oxolinic acid in healthy women. Clin Pharmacol Ther (1976) 0.97

Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res (1997) 0.97

New selective COMT inhibitors: useful adjuncts for Parkinson's disease? Trends Pharmacol Sci (1989) 0.96

Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl (1995) 0.96

7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) (1997) 0.95

A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease. Br J Pharmacol (2012) 0.92

Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values. Med Hypotheses (2001) 0.91

Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology (2000) 0.91

Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner. Br J Pharmacol (2011) 0.91

Endocytotic pathways in the melanotroph of the rat pituitary. Histochem J (1993) 0.91

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. Gen Pharmacol (1994) 0.91

Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state. J Antimicrob Chemother (1988) 0.91

A new monoclonal antibody against the GABA-protein conjugate shows immunoreactivity in sensory neurons of the rat. Neuroscience (1992) 0.90

The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa. Acta Neurol Scand (1985) 0.90

Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis. Dig Dis Sci (1995) 0.89

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers. Clin Neuropharmacol (1995) 0.88

Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci (2000) 0.88

Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol (1984) 0.88

Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat. J Neural Transm (1987) 0.88

Inverse relationship between cardiorespiratory fitness and carotid atherosclerosis. Atherosclerosis (1995) 0.87

Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. Eur J Pharmacol (1999) 0.87

Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience (2008) 0.87

Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro. J Antimicrob Chemother (1988) 0.86

Quantitative comparison of growth-associated protein GAP-43, neuron-specific enolase, and protein gene product 9.5 as neuronal markers in mature human intestine. J Histochem Cytochem (1999) 0.85

Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berl) (2001) 0.85

Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice. Carcinogenesis (1986) 0.84

Effects of systemic carbidopa on dopamine synthesis in rat hypothalamus and striatum. J Neural Transm Park Dis Dement Sect (1992) 0.84

Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Clin Exp Immunol (2011) 0.84

Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.84

Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat. Acta Endocrinol (Copenh) (1979) 0.84

Tonsillar penetration of erythromycin and its 2'-acetyl ester in patients with chronic tonsillitis. J Antimicrob Chemother (1988) 0.84

Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. Alcohol Clin Exp Res (2001) 0.84

Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother (1985) 0.83

Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats. J Neural Transm Park Dis Dement Sect (1990) 0.83

Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur J Pharmacol (1993) 0.83

Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo. Neuroscience (2011) 0.83

Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers. Antimicrob Agents Chemother (1984) 0.83

Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study. Neuroscience (2008) 0.82

Effect of pre- and postganglionic nerve divisions on normal postnatal and hydrocortisone-induced development of small intensely fluorescent cells in rat superior cervical ganglion. Neuroscience (1982) 0.82

Beneficial effects of a potassium- and magnesium-enriched salt alternative. Hypertension (1992) 0.81

Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice. Br J Pharmacol (2009) 0.81

Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.81

Effect of pre- and/or postganglionic nerve division on hydrocortisone-induced small intensely fluorescent cells in the rat superior cervical ganglion. Neuroscience (1984) 0.81

Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base. J Antimicrob Chemother (1988) 0.81

Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis. J Histochem Cytochem (2001) 0.81

Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells. Dev Biol (1987) 0.81

Neurotrophins and their receptors in the rat pituitary gland: regulation of BDNF and trkB mRNA levels by adrenal hormones. Brain Res Mol Brain Res (1994) 0.81

Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig Dis Sci (1996) 0.81

Effects of aqueous extracts of Halimeda incrassata (Ellis) Lamouroux and Bryothamnion triquetrum (S.G.Gmelim) Howe on hydrogen peroxide and methyl mercury-induced oxidative stress in GT1-7 mouse hypothalamic immortalized cells. Phytomedicine (2003) 0.80

Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity. Kidney Int (2000) 0.80

Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases. Neuroscience (2013) 0.80

No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats. Eur J Pharmacol (1998) 0.80

Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats. Pharmacol Toxicol (1999) 0.80

Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease. Mov Disord (1997) 0.79

Regulation of secretory granule formation in chronically hypersecretory melanotrophs in the rat pituitary. Cell Tissue Res (1994) 0.79

Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis. Scand J Gastroenterol (2001) 0.79

Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. Clin Exp Immunol (2010) 0.79

Pharmacokinetics of clofibrate and chlorophenoxy isobutyric aicd. I. Cross-over studies on human volunteers. Acta Pharmacol Toxicol (Copenh) (1975) 0.79

L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats. Eur J Pharmacol (1998) 0.79

Different renal effects of two inhibitors of catechol-O-methylation in the rat: entacapone and CGP 28014. Acta Physiol Scand (1998) 0.79

Inhibitors of catechol-O-methyltransferase sensitize mice to pain. Br J Pharmacol (2010) 0.79

Physical activity and health-related fitness in middle-aged men. Med Sci Sports Exerc (1995) 0.79

Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives. J Med Chem (1999) 0.79

Effect of nitecapone and clorgyline, given intracerebro-ventricularly on L-dopa metabolism in the rat brain. Neuroreport (1992) 0.79

Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation. Psychopharmacology (Berl) (1998) 0.78

Inhibition of the TSH secretion by histamine in male rats. Acta Endocrinol (Copenh) (1983) 0.78

Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations. J Psychiatry Neurosci (2000) 0.78

Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease. Neuromuscul Disord (2000) 0.78

Histamine-immunoreactive endocrine cells in the adrenal medulla of the rat. Brain Res (1985) 0.78

NADPH-diaphorase activity and its colocalization with transmitters and neuropeptides in the postganglionic neurons of the rat superior cervical ganglion. Brain Res (1994) 0.78

Serotonin is not synthesized, but specifically transported in the neurons of the hypothalamic dorsomedial nucleus. Eur J Neurosci (1998) 0.78

Modification of GABAergic activity and thyrotropin secretion in male rats. Acta Pharmacol Toxicol (Copenh) (1980) 0.78

Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats. Neuropeptides (1989) 0.78

Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze. Neuropeptides (1994) 0.78

Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport (1995) 0.78

Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels. Eur Neuropsychopharmacol (1997) 0.78

Intravenous cefuroxime prophylaxis. Tissue levels after one 3-gram dose in 40 cases of hip fracture. Acta Orthop Scand (1995) 0.78

Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate. Antimicrob Agents Chemother (1988) 0.78

Nitric oxide synthase in the hypothalamo-pituitary pathways. J Chem Neuroanat (1995) 0.78

The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat. Pflugers Arch (2001) 0.78

Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur J Pharmacol (1993) 0.78

Studies on the site and mechanism of the inhibitory action of intracerebral histamine on the cold-stimulated thyrotropin secretion in male rats. Brain Res (1985) 0.78

N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur J Pharmacol (1994) 0.78

Further evidence of the dual role of noradrenaline in regulation of thyrotrophin secretion in male rats. Acta Endocrinol (Copenh) (1981) 0.78